Structure Info
- Chemspace ID
- CSSB00161189048 (In-Stock Building Blocks)
- CAS
- 2230821-27-7
- MFCD
- MFCD32062811
- IUPAC Name
- (2S,4R)-1-[(2S)-2-[3-(2-{[5-({4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)pentyl]oxy}ethoxy)propanamido]-3,3-dimethylbutanoyl]-4-hydroxy-N-{[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl}pyrrolidine-2-carboxamide
- Mol formula
- C47H57ClFN7O8S
- Mol weight
- 935 Da
- Catalog Number(s)
- 28597, 198574, A346407, AA01JK4G, ACS-2952, AG01JK78, AR01JKW8, AZ92060, BD00774997, BH92060, BISN0057, BP-28379, CS-0087480, CSC161189048, D80333, F986380, FPD82127, G223000, HY-123921, LAN-B67889, T5437, Y1012751
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 5.43
- Heavy atoms count
- 65
- Rotatable bond count
- 23
- Number of rings
- 6
- Carbon bond saturation, Fsp3
- 0.446
- Polar surface area (Å)
- 186
- Hydrogen bond acceptors count
- 12
- Hydrogen bond donors count
- 4
- Zoom the structure
- CSSB00161189048
Items Overall 35 items from 9 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
BLD Pharmatech Co., Limited | 1 day | United States To: | 99 | 1 mg | 21 | |
BLD Pharmatech Co., Limited | 1 day | United States To: | 99 | 5 mg | 41 | |
BLD Pharmatech Co., Limited | 1 day | United States To: | 99 | 10 mg | 60 | |
BLD Pharmatech Co., Limited | 1 day | United States To: | 99 | 25 mg | 107 | |
BLD Pharmatech Co., Limited | 1 day | United States To: | 99 | 50 mg | 180 | |
BLD Pharmatech Co., Limited | 1 day | United States To: | 99 | 100 mg | 306 | |
Description: Name:(2S,4R)-1-((S)-2-(3-(2-((5-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)pentyl)oxy)ethoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide; CAS: 2230821-27-7 | ||||||
BLD PHARMATECH LTD CN | 1 day | China To: | 99 | 1 mg | 21 | |
BLD PHARMATECH LTD CN | 1 day | China To: | 99 | 5 mg | 41 | |
BLD PHARMATECH LTD CN | 1 day | China To: | 99 | 10 mg | 60 | |
BLD PHARMATECH LTD CN | 1 day | China To: | 99 | 25 mg | 107 | |
BLD PHARMATECH LTD CN | 1 day | China To: | 99 | 50 mg | 180 | |
BLD PHARMATECH LTD CN | 1 day | China To: | 99 | 100 mg | 306 | |
Description: Name:(2S,4R)-1-((S)-2-(3-(2-((5-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)pentyl)oxy)ethoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide; CAS: 2230821-27-7 | ||||||
BLD Pharmatech GmbH | 1 day | Germany To: | 99 | 25 mg | 107 | |
Description: Name:(2S,4R)-1-((S)-2-(3-(2-((5-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)pentyl)oxy)ethoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide; CAS: 2230821-27-7 | ||||||
Angene International Limited | 5 days | China To: | 99 | 1 mg | 16 | |
Angene International Limited | 5 days | China To: | 99 | 5 mg | 33 | |
Angene International Limited | 5 days | China To: | 99 | 10 mg | 48 | |
Angene International Limited | 5 days | China To: | 99 | 25 mg | 96 | |
Angene International Limited | 5 days | China To: | 99 | 50 mg | 162 | |
Angene International Limited | 5 days | China To: | 99 | 100 mg | 272 | |
Description: Gefitinib-based PROTAC 3; CAS: 2230821-27-7 | ||||||
Astatech CN | 10 days | China To: | 95 | 5 mg | 186 | |
Astatech CN | 10 days | China To: | 95 | 10 mg | 296 | |
Description: GEFITINIB-BASED PROTAC 3; CAS: 2230821-27-7 | ||||||
AA BLOCKS | 12 days | United States To: | 99 | 1 mg | 16 | |
AA BLOCKS | 12 days | United States To: | 99 | 5 mg | 64 | |
AA BLOCKS | 12 days | United States To: | 99 | 10 mg | 78 | |
AA BLOCKS | 12 days | United States To: | 99 | 25 mg | 95 | |
Description: Gefitinib-Based PROTAC 3; CAS: 2230821-27-7 | ||||||
A2B Chem | 12 days | United States To: | 90 | 1 mg | 29 | |
A2B Chem | 12 days | United States To: | 90 | 5 mg | 93 | |
A2B Chem | 12 days | United States To: | 90 | 10 mg | 159 | |
A2B Chem | 12 days | United States To: | 90 | 25 mg | 288 | |
Description: Gefitinib-based PROTAC 3; CAS: 2230821-27-7 | ||||||
ChemScene CN | 15 days | China To: | 98 | 5 mg | 132 | |
ChemScene CN | 15 days | China To: | 98 | 10 mg | 220 | |
Description: Gefitinib-based PROTAC 3; CAS: 2230821-27-7 | ||||||
Broadpharm | 20 days | United States To: | 90 | 5 mg | 94 | |
Broadpharm | 20 days | United States To: | 90 | 10 mg | 165 | |
Broadpharm | 20 days | United States To: | 90 | 25 mg | 308 | |
Broadpharm | 20 days | United States To: | 90 | 50 mg | 495 | |
Description: Gefitinib-based PROTAC 3; CAS: 2230821-27-7 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire